by Lance Smith | May 29, 2019 | Study Scavenger Clinical Trial Recruitment Platform
A bioengineered human acellular vessel may help veterans with kidney failure The VA Pittsburgh Healthcare System (VAPHS) in collaboration with the Veterans Research Foundation of Pittsburgh (VRFP) is participating in the first-of-its-kind clinical trial that will help...by Lance Smith | May 29, 2019 | Study Scavenger Clinical Trial Recruitment Platform
. Make recommendations and changes along the way to improve recruitment efforts. By having a successful recruitment campaign, you’ll attain the ideal patients for your trial and have a higher chance of retainment. Once patients are enrolled and the trials begin,...by Lance Smith | May 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
– Test shows overall weighted average sensitivity of 90.1% (94.7%) and overall weighted average specificity of 98.4% (97.9%) in prospective (retrospective) sample cohort – U.S. FDA 510(k) submission for Unyvero LRT BAL Application Cartridge in preparation...by Lance Smith | May 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
On Friday, Antisense Therapeutics Limited (ASX: ANP) announced that Phase II clinical trial of its immunomodulatory therapy, ATL1102 for Duchenne Muscular Dystrophy (DMD) is now fully enrolled. The trial is an open-label six-month dosage trial and is being carried out...by Lance Smith | May 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Alteogen Inc. (CEO Soon Jae Park), a South Korean biotechnology company developing Eylea biosimilar (ALT-L9) to treat macular degeneration, announced that it gained Investigational New Drug (IND) approval for Phase 1 clinical trial from Ministry of Food and Drug...by Lance Smith | May 25, 2019 | Study Scavenger Clinical Trial Recruitment Platform
TROPHY1 data presented in Late-Breaking Trial Session at EuroPCR 2019 SoniVie, an Israeli company developing a novel system for the treatment of pulmonary arterial hypertension (PAH), today announced the presentation of positive data from a multi-center international...